IndegeneBOM:544172 -1.45%49 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:544172 with a GF Score™ of 49/100. The stock has 5 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Indegene ranks better than 78.14% on this metric.
The historical rank and industry rank for Indegene's OCF Margin % or its related term are showing as below:
BOM:544172'
s OCF Margin % Range Over the Past 10 Years
Min: 5.65 Med: 17.82 Max: 19.61
Current: 18.54
During the past 6 years, the highest OCF Margin % of Indegene was 19.61%. The lowest was 5.65%. And the median was 17.82%.
BOM:544172's OCF Margin % is ranked better than 78.14% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 8.33
vs BOM:544172: 18.54
Indegene OCF Margin % Related Terms
Indegene OCF Margin % Historical Data
* Premium members only.
The historical data trend for Indegene's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544172 vs VEEV, BTSG, TEM: OCF Margin % Comparison
For the Health Information Services subindustry, Indegene's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indegene OCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indegene's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Indegene's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indegene (BOM:544172) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Indegene and its competitors. Over the past decade, Indegene's OCF Margin % has ranged from 5.65 to 19.61. According to the industry distribution chart, Indegene ranks #146 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 21.9%.
Is Indegene's OCF Margin % too high?
Indegene's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 5.65 to a high of 19.61. Based on the distribution chart, Indegene ranks #146 out of 668 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Indegene has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's OCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Indegene ranks #146 out of 668 companies for OCF Margin %. This places Indegene in the top 22% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 8.33. Historically, Indegene's own OCF Margin % has ranged from 5.65 to 19.61 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Providers & Services company?
The median OCF Margin % among Healthcare Providers & Services companies is 8.33, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Indegene and its competitors. For the Healthcare Providers & Services industry, the median OCF Margin % is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indegene's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (BOM:544172) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Indegene's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Indegene (BOM:544172), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score
Get the complete analysis for BOM:544172
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544172 has been successfully added to your 
